Description: Mortality improvement for the U.S. general population has stagnated in recent years and then further deteriorated with the COVID-19 pandemic. However, mortality improvement by socioeconomic factors such as education and income has varied widely during this time period. Explore with us cause-of-death mortality rate trends as well as overall mortality improvement trends by different socioeconomic factors. Join a discussion on approaches that companies can take to proxy the insured population by applying socioeconomic factors to the general population with the goal of better understanding future mortality trends for the insured population.

Description: This session will bring together public health care leaders in COVID-10 vaccine delivery from both the U.S. and the UK to discuss and compare operational implications of the COVID-19 vaccine rollout in their countries, and how those programs ultimately affected hospitalization utilization and mortality rates for members of their communities.

Description: Since its inception, the Society of Actuaries (SOA) Research Institute's Mortality and Longevity Strategic Research Program has introduced studies to provide insights into historical and future U.S. population mortality trends. Learn about the recent focus to understand the growing mortality differences in the U.S. Come discover an overview of the research underway. Discuss the latest findings including how COVID-19 has impacted socioeconomic inequalities in U.S. mortality as well as how health status contributes to U.S. mortality.

Description: The United Kingdom makes public an impressive body of data about its population, its health system (the NHS), and the care which the NHS provides to the nation. This session will take the audience on a tour of many of these sets - with a focus on uncovering healthcare disparities. For context, a brief description of the NHS in England, population characteristics of England, and how social determinants of health (SDOH) are quantified will be given. With these as a background, we will explore data on chronic disease prevalence and incidence as well as physician performance against targets. We will present examples of health disparities from this data for certain conditions. Datasets of UK prescribing will be shown for further detail. The closing portion of this talk will present similar public domain US data - and how the UK body of information can assist in understanding health disparities in the US.

Description: The COVID-19 pandemic has been an acute reminder of the material impacts that pandemics can have on Life (re)insurance and society at large. Learn to describe the journey of a Life reinsurance practitioner to model and operationalize pandemic and infectious disease risk, why this is of importance to actuaries, and their risk management. It will consider how such models have been used, developments over time, and challenges in using and calibrating these models. The session will also provide perspectives from a pandemic model provider who will describe the fundamental metrics for pandemic loss distributions and how learnings from the COVID-19 pandemic can be used to quantify the potential impact of the next pandemic. Finally, dive into an outline of how biological principles can be applied to anticipating plausible pathogens causing the next pandemic.

Description: What are the recent trends in mortality? Should we expect different mortality experience in a post-COVID-19 world? Join us as we review the latest emerging trends in U.S. population mortality.by the end of this session, you will understand the impact of COVID-19 on future mortality experience. You will also have an awareness of other major causes of mortality and how they are trending.

Description: As we entered 2014, actuaries became familiar with three risk stabilizing mechanisms in the early years of the ACA marketplaces, colloquially known as 'the 3Rs'. As we enter 2024, there is renewed focus on rating compliance and risk adjustment. Speakers will highlight pricing considerations when determining cost-sharing reduction premium loads as well as related issues pertaining to risk adjustment and metal tier pricing.

Description: Recent and potential near future extreme experiences are leading us to a new normal rather than back to the prior environment. Learn more about several examples of past Regime Changes along with a detailed discussion of how recent disruptions lead toward a persistent change in the business, social and political environment. Come develop an understanding of these drivers of change as well as the likely impacts on the Financial Services industry.

Description: Cardiovascular disease (CVD) remains the leading cause of death among older adults in the United States. While genetics play a foundational role in establishing risk, disease progression is heavily shaped by lifestyle behaviors, environmental exposures, and social determinants of health. This Webcast will summarize key insights from an expert panel discussion on the evolving landscape of cardiovascular mortality at older ages.

Description: What are the recent expectations of long-term trends in mortality? What are the limits to improvements in longevity? Join us as we review the factors impacting U.S. population mortality in the eyes of demographers. By the end of this session, you will have an awareness of the major causes of mortality and how they are trending.